Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7057
Rank
NZ$0.91 B
Marketcap
NZ$45.56
Share price
-0.56%
Change (1 day)
-23.79%
Change (1 year)

Financial Statements

Thumbnail Avalon Pharma (Middle East Pharmaceutical) Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement